Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Bliss GVS Pharma Community
NSEI:BLISSGVS Community
1
Narratives
written by author
0
Comments
on narratives written by author
1
Fair Values set
on narratives written by author
Community Investing Ideas
Bliss GVS Pharma
Popular
Undervalued
Overvalued
Bliss GVS Pharma
SN
SNKRRMGM
Community Contributor
Bliss GVS Pharma will boost profits with 12.79% margin surge
Trading at a low P/E ratio relative to near-term earnings growth
View narrative
₹165.84
FV
2.1% overvalued
intrinsic discount
11.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
Your Valuation for
BLISSGVS
BLISSGVS
Bliss GVS Pharma
Your Fair Value
₹
Current Price
₹169.34
31.8% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
12b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹11.8b
Earnings ₹1.5b
Advanced
Set Fair Value